北美过敏治疗市场预测至 2028 年 - COVID-19 影响和按过敏类型(眼部过敏、鼻炎、哮喘、皮肤过敏、食物过敏和其他过敏)和治疗(抗过敏药物和免疫疗法)进行的区域分析

Historic Data: 2018-2019   |   Base Year: 2020   |   Forecast Period: 2021-2028


No. of Pages: 130    |    Report Code: TIPRE00022075    |    Category: Life Sciences

North America Allergy Treatment Market

市场介绍

过敏是人体免疫系统对与身体接触的物质产生的过敏反应。严重过敏可能会危及生命,它会扰乱器官的正常功能,例如哮喘会导致肺部功能不良。治疗过敏最有效的方法是避免已知的过敏原,而类固醇和抗组胺药等药物以及其他疗法可以预防过敏。

 < /p>

市场概况与动态

北美过敏治疗市场预计到2028年将达到1094067万美元2020 年为 66.4604 亿美元;预计2021年至2028年复合年增长率为6.5%。市场的增长归因于过敏治疗中免疫疗法的日益采用以及食物过敏治疗的发展。然而,缺乏对过敏治疗的认识是制约市场增长的关键因素。

 

主要细分市场

北美过敏治疗市场根据过敏类型分为眼过敏、鼻炎、哮喘、皮肤过敏、食物过敏、和其他过敏。 2020年,鼻炎细分市场占据最大市场份额,而食物过敏细分市场预计在未来几年将以最快的速度增长。

北美过敏治疗市场,根据治疗方式分为抗过敏药物和免疫治疗。 2020年,抗过敏药物领域占据最大市场份额。然而,免疫疗法预计在未来几年将以最快的速度增长。

 

主要来源和上市公司

与本北美过敏治疗市场报告相关的一些主要和次要来源是美国过敏、哮喘和疾病学会免疫学 (AAAAI)、美国哮喘和过敏基金会 (AAA) 以及美国国立卫生研究院 (NIH)。

 

购买报告的理由

  • 确定潜在投资基于未来几年北美过敏治疗市场 详细趋势分析。
  • 深入了解推动支出最高的国家/地区不同成瘾治疗药物细分市场需求的根本因素,并发现机会
  • 加强您对市场需求驱动因素、行业趋势和最新技术发展等方面的了解。
  • 确定推动北美过敏治疗市场的主要渠道北美过敏治疗市场提供未来机会的清晰画面,这将有助于分析,从而增加收入。
  • 通过关注不同国家/地区正在进行的项目来引导资源 北美过敏治疗市场

 

北美过敏治疗市场细分

作者过敏类型

  • 眼睛过敏
  • 鼻炎
  • 哮喘
  • 皮肤过敏
  • 食物过敏
  • 其他过敏

作者

治疗

  • 抗过敏药物< /li>
  • 抗组胺药
  • 皮质类固醇
  • 减充血剂
  • 其他药物
  • 免疫治疗
  • 皮下免疫治疗 (SCIT)
  • 舌下免疫治疗 (SLIT)

< strong>按国家/地区

  • 美国
  • 加拿大
  • 墨西哥

公司简介

  • 强生服务公司
  • 赛诺菲
  • 艾伯维公司
  • 辉瑞
  • ALK-Abelló; A/S
  • 过敏治疗
  • Stallergenes Greer
  • 葛兰素史克PLC
 

North America Allergy Treatment Strategic Insights

Strategic insights for North America Allergy Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-allergy-treatment-market-strategic-framework.webp
Get more information on this report

North America Allergy Treatment Report Scope

Report Attribute Details
Market size in 2020 US$ 6,646.04 Million
Market Size by 2028 US$ 10,940.67 Million
Global CAGR (2021 - 2028) 6.5%
Historical Data 2018-2019
Forecast period 2021-2028
Segments Covered By 过敏类型
  • 眼部过敏
  • 鼻炎
  • 哮喘
  • 皮肤过敏
  • 食物过敏
  • 其他过敏
By 治疗
  • 抗过敏药物
  • 免疫疗法
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Johnson and Johnson Services, Inc.
  • Sanofi
  • AbbVies Inc.
  • Pfizer
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • GlaxoSmithKline PLC
  • Get more information on this report

    North America Allergy Treatment Regional Insights

    The regional scope of North America Allergy Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-allergy-treatment-market-geography.webp
    Get more information on this report

    The List of Companies - North America Allergy Treatment Market

    The List of Companies - North America Allergy Treatment Market 

    1. Johnson and Johnson Services, Inc.
    2. Sanofi
    3. AbbVie's Inc.
    4. Pfizer
    5. ALK-Abelló A/S
    6. Allergy Therapeutics
    7. Stallergenes Greer
    8. GlaxoSmithKline PLC
    Frequently Asked Questions
    How big is the North America Allergy Treatment Market?

    The North America Allergy Treatment Market is valued at US$ 6,646.04 Million in 2020, it is projected to reach US$ 10,940.67 Million by 2028.

    What is the CAGR for North America Allergy Treatment Market by (2021 - 2028)?

    As per our report North America Allergy Treatment Market, the market size is valued at US$ 6,646.04 Million in 2020, projecting it to reach US$ 10,940.67 Million by 2028. This translates to a CAGR of approximately 6.5% during the forecast period.

    What segments are covered in this report?

    The North America Allergy Treatment Market report typically cover these key segments-

  • 过敏类型 (眼部过敏, 鼻炎, 哮喘, 皮肤过敏, 食物过敏, 其他过敏)
  • 治疗 (抗过敏药物, 免疫疗法)
  • What is the historic period, base year, and forecast period taken for North America Allergy Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Allergy Treatment Market report:

  • Historic Period : 2018-2019
  • Base Year : 2020
  • Forecast Period : 2021-2028
  • Who are the major players in North America Allergy Treatment Market?

    The North America Allergy Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Johnson and Johnson Services, Inc.
  • Sanofi
  • AbbVies Inc.
  • Pfizer
  • ALK-Abelló A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • GlaxoSmithKline PLC
  • Who should buy this report?

    The North America Allergy Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Allergy Treatment Market value chain can benefit from the information contained in a comprehensive market report.